Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in anaplastic thyroid cancer
NCT02516774Phase 1Withdrawn
- Sponsor
- Gustave Roussy
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 1, open-label trial of adalimumab in anaplastic thyroid cancer (ATC), sponsored by Gustave Roussy. Planned start Dec 2014; status: withdrawn.
02
Drugs
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT02516774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516774.